C7ORF42 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.616600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.990200E-01
Normal-vs-Stage2
5.749600E-01
Normal-vs-Stage3
6.667400E-01
Normal-vs-Stage4
2.280300E-02
Stage1-vs-Stage2
9.495800E-01
Stage1-vs-Stage3
3.891600E-01
Stage1-vs-Stage4
1.281920E-02
Stage2-vs-Stage3
1.742580E-01
Stage2-vs-Stage4
1.060440E-01
Stage3-vs-Stage4
6.486000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.816400E-01
Normal-vs-AfricanAmerican
2.063400E-01
Normal-vs-Asian
9.825000E-01
Caucasian-vs-AfricanAmerican
3.453600E-01
Caucasian-vs-Asian
3.304400E-01
AfricanAmerican-vs-Asian
1.818040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.613200E-01
Normal-vs-Female
5.750600E-01
Male-vs-Female
5.576000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.454400E-01
Normal-vs-Age(41-60Yrs)
1.092830E-01
Normal-vs-Age(61-80Yrs)
8.208000E-01
Normal-vs-Age(81-100Yrs)
6.801000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.192800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.242200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.140200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.448860E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.148190E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.271800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.407800E-01
Normal-vs-Daily Drinker
8.673200E-01
Normal-vs-Weekly Drinker
6.457000E-01
Normal-vs-Occasional Drinker
3.080200E-01
Normal-vs-Social Drinker
3.291000E-01
Non Drinker-vs-Daily Drinker
5.988800E-01
Non Drinker-vs-Weekly Drinker
2.727400E-01
Non Drinker-vs-Occasional Drinker
3.726400E-02
Non Drinker-vs-Social Drinker
1.807700E-02
Daily Drinker-vs-Weekly Drinker
5.687200E-01
Daily Drinker-vs-Occasional Drinker
1.682160E-01
Daily Drinker-vs-Social Drinker
8.429900E-02
Weekly Drinker-vs-Occasional Drinker
5.350600E-01
Weekly Drinker-vs-Social Drinker
3.010400E-01
Occasional Drinker-vs-Social Drinker
4.919000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.069600E-01
Normal-vs-Grade 2
5.692200E-01
Normal-vs-Grade 3
5.681800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.403600E-01
Grade 1-vs-Grade 3
3.700600E-01
Grade 1-vs-Grade 4
2.069600E-01
Grade 2-vs-Grade 3
9.599600E-01
Grade 2-vs-Grade 4
5.692200E-01
Grade 3-vs-Grade 4
5.681800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.734600E-01
Normal-vs-NonDiabetic
4.853400E-01
Diabetic-vs-NonDiabetic
4.367900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.581200E-01
Normal-vs-NoPancreatitis
6.415200E-01
Pancreatitis-vs-NoPancreatitis
4.721800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.124200E-01
Normal-vs-N1
5.573800E-01
N0-vs-N1
6.323200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.246800E-01
Normal-vs-TP53-NonMutant
5.482400E-01
TP53-Mutant-vs-TP53-NonMutant
7.958600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
